Efficacy of Electronic Cigarettes Noninferior to Varenicline
TUESDAY, Jan. 30, 2024 -- For smokers who are motivated to quit, the quit rate is noninferior for electronic cigarettes (ECs) versus varenicline and is higher for ECs than nicotine replacement therapy (NRT) in the form of nicotine gum, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2024 Category: Pharmaceuticals Source Type: news
e-Cigarettes Best Nicotine Gum for Smoking Cessation e-Cigarettes Best Nicotine Gum for Smoking Cessation
The devices were as effective as varenicline in a randomized trial, but questions about their safety remain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2024 Category: Consumer Health News Tags: Internal Medicine Source Type: news
Lupin introduces generic product in US market
Drug firm Lupin on Wednesday said it has launched a product, used as an aid to smoking cessation treatment, in the US market. The company has launched Varenicline tablets in strengths of 0.5 mg and 1 mg, after having received approval from the US Food and Drug Administration (USFDA), the Mumbai-based drug maker said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news
Lupin gets USFDA nod for generic smoking cessation treatment tablets
Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic Varenicline tablets indicated for use as an aid to smoking cessation treatment. The approval by the US FDA is for the abbreviated new drug application for Varenicline tablets of strengths 0.5 mg and 1 mg, Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2023 Category: Pharmaceuticals Source Type: news
E-Cigarettes, Cytisine, Varenicline Most Effective to Help Stop Smoking
FRIDAY, Sept. 15, 2023 -- Electronic cigarettes and the medicines cytisine and varenicline appear to help the most people to quit smoking, according to a review published online Sept. 12 in the Cochrane Library.
Nicola Lindson, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 15, 2023 Category: Pharmaceuticals Source Type: news
Smokers more likely to quit using e-cigarettes or medicines
Smokers are more likely to quit using e-cigarettes or smoking cessation medicines, according to a new analysis led by the University of Oxford. In a review of over 300 clinical trials, researchers found that the most effective way to help people stop smoking is through the use of e-cigarettes and medicines such as varenicline and... Read moreThe post Smokers more likely to quit using e-cigarettes or medicines appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - September 14, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Addiction and mental health Clinical Source Type: news
E-cigarettes, varenicline and cytisine are the most effective stop-smoking aids, analysis of over 150,000 smokers reveals
Key Points Comprehensive study reveals nicotine e-cigarettes, varenicline and cytisine are the stop-smoking aids most likely to help people quit smoking.On average, for every 100 people trying to quit, around 14 are likely to succeed using an e-cigarette, varenicline or cytisine in any given quit attempt. This is compared to 6 in 100 who are likely to quit without using any aids.Dual nicotine replacement therapy (NRT) methods, like combining a patch with gum, may be almost as effective, with approximately 12 in 100 people likely to successfully quit. However, this estimate is less certain than those for the other stop-sm...
Source: Cochrane News and Events - September 11, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
La FDA revisa la descripci ón de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropión) para reflejar las conclusiones de estudio clínico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 25, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
An FDA review found the side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) are lower than previously suspected. These risks still exist, but we believe the benefits of quitting smoking outweigh them. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 11, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Adaptation to Pharmacotherapy Does Not Up Smoking Cessation in Black Adults
TUESDAY, June 27, 2023 -- For Black adults who smoke, adaptation to varenicline and/or bupropion plus nicotine patch (NP) does not improve abstinence rates compared with NP monotherapy, according to a study published online June 20 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2023 Category: Pharmaceuticals Source Type: news
Can medications like varenicline and cytisine (nicotine receptor partial agonists) help people to stop smoking and do they cause unwanted effects?
Friday, May 5, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - May 5, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Should we ban the purchase of cigarettes for life? A US town is trying
Mary Jo began smoking when she was 12 years old, sneaking behind her church and picking up cigarette butts off the ground. As she got a little older, she would steal cigarettes from her brother and, by 15, she was buying her own packs – a proud Marlboro smoker. “I smoked for 30 years,” she tells…#maryjo #marlboro #wilmington #massachusetts #cigarettes #chantix #maryjos #katherinesilbaugh #brookline #boston (Source: Reuters: Health)
Source: Reuters: Health - March 31, 2023 Category: Consumer Health News Source Type: news
With acquisition, vision and deep pockets, Kriya Therapeutics eyes new day for gene therapy
One of the acquired programs — coupling gene therapy with the generic smoking cessation drug Chantix to quell hyperactive neurons in epilepsy patients — could be ready for a clinical trial next year or 2024. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 16, 2022 Category: American Health Authors: Ron Leuty Source Type: news
Tobacco: preventing uptake, promoting quitting and treating dependence [NG209], NICE (updated 4th August 2022)
This guideline covers support to stop smoking for everyone aged 12 and over, and help to reduce people ' s harm from smoking if they are not ready to stop in one go. It also covers ways to prevent children, young people and young adults aged 24 and under from taking up smoking. The guideline brings together and updates all NICE ' s previous guidelines on using tobacco, including smokeless tobacco. It covers nicotine replacement therapy and e-cigarettes to help people stop smoking or reduce their harm from smoking. It does not cover using tobacco products such as ' heat not burn ' tobacco.
In August 2022, we reviewed the e...
Source: Current Awareness Service for Health (CASH) - August 4, 2022 Category: Consumer Health News Source Type: news
Mortality Rates and Voting; Varenicline and Smoking in African Americans
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 18, 2022 Category: Endocrinology Source Type: news
